These are prescription drugs, full stop
Semaglutide and tirzepatide — the medications behind Ozempic, Wegovy, Zepbound, and Mounjaro — are prescription drugs. That means a licensed prescriber (a physician, nurse practitioner, or physician assistant) has to actually evaluate you first: a real exam, your medical history, your contraindications, and a dose that gets adjusted over time.
The red flag is the opposite of that. A two-minute web form, no real evaluation, and a vial in the mail is not a medical program — it's a mail-order gamble with a powerful drug. The medication can be perfectly legitimate while the oversight around it is not.
Compounded vs. brand-name
Many med spas use compounded semaglutide or tirzepatide — versions mixed by a compounding pharmacy, usually cheaper than the brand-name pens. Compounded medication can be legitimate when your prescriber decides you need something the approved drug can't give you and it comes from a properly licensed pharmacy. But the FDA took tirzepatide off its shortage list in December 2024 and semaglutide in February 2025, and since then pharmacies are not allowed to routinely make copies of the brand-name drugs. Quality varies, and a compounded drug isn't FDA-approved at all: the FDA doesn't review compounded drugs for safety, effectiveness, or quality.
So ask three questions: where is it compounded, is that pharmacy licensed, and why am I getting the compounded version instead of the approved one? A good program answers without hesitation. A vague answer is a reason to slow down.
What a safe program actually looks like
A safe GLP-1 program has a real prescriber who examines you, knows your history, starts low and titrates up, follows up on how you're doing, and is reachable if something feels off. The single most useful question you can ask is: who is the prescriber, and will I actually deal with them?
If the answer is a real, named, licensed person — good. If it's a shrug and a vial, that's your sign to keep looking.
Find a med spa on the register